Although carbon ion radiation led to a decline in urinary function among patients with prostate cancer, function returned to ...

In a strong validation of the company’s clinical trial, Imugene Ltd’s Phase 1b trial for its azer-cel off-the-shelf, allogeneic, CD19 CAR T therapy in relapsed/refractory diffuse large B-cell lymphoma ...

Ryoncil ® was approved in December 2024 by the United States Food and Drug Administration (FDA) for steroid-refractory acute ...

Recursion is advancing REC-617, a promising reversible, non-covalent CDK7 inhibitor, showing potential in treating advanced ...

The Protein Sequencing Companytm, and several distinguished researchers will highlight advances in Next-Generation Protein Sequencingtm (NGPStm) at the US Human Proteome ...

The Protein Sequencing Company ™, and several distinguished researchers will highlight advances in Next-Generation Protein Sequencing™ (NGPS™) at the US Human Proteome Organization’s 2025 conference ...

Cade, Telix Group Chief Medical Officer, said, “Telix will feature in four presentations at this year’s ASCO GU, which showcase the depth and differentiation of our therapeutic urologic pipeline, ...

The 44th annual Foley Arbor Day is Saturday, Feb. 22. Residents can pick up a free tree to plant in their backyard. The city will give away 675 trees, each planted in 3-gallon ...

Many of Cattaraugus County’s 4-H members showcased their public speaking talents in recent days, presenting on topics from ...

Over 230 patients enrolled in potential registration-enabling trial in 1L HLA-A2-negative MUM, and median PFS readout targeted by year-end 2025 95 patients enrolled ...

The Special Commission on Combating Antisemitism has gathered more than two dozen examples of learning materials that ...